Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapyMegan M. Tu, Dan Theodorescu, Katelyn J. Hoff et al.|Communications Biology|2020Cited by 170
Sarcomatoid Renal Cell Carcinoma Has a Distinct Molecular Pathogenesis, Driver Mutation Profile, and Transcriptional LandscapeZixing Wang, Kanishka Sircar, Tae Beom Kim et al.|Clinical Cancer Research|2017Cited by 94
Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive BehaviorAaron Mobley, Bogdan Czerniak|Scientific Reports|2017Cited by 49
Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder CancerCharles C. Guo, Bogdan Czerniak|bioRxiv (Cold Spring Harbor Laboratory)|2018Cited by 21